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Abstract
Background: N-cadherin is a trans-membrane adhesion molecule associated with advanced carcinoma progression
and poor prognosis. The effect of N-cadherin on matrix metalloproteinase 9 (MMP-9) regulation is implicated in
human nasopharyngeal carcinoma (NPC) cell invasion.
Methods and results: Exposure of NPC cells to phorbol-12-myristate-13-acetate (PMA) or macrophage conditioned
media (CM) upregulated MMP-9 and N-cadherin cleavage, which resulted in NPC cell invasion. MMP-9 cleaved the
extracellular domain of N-cadherin, which was further cleaved by γ-secretase with PMA or macrophage-CM treatment.
The extracellular cleavage of N-cadherin was inhibited with treatment with an MMP inhibitor and MMP-9 siRNA,
whereas the intracellular cleavage of N-cadherin was inhibited by treatment with a γ-secretase inhibitor (γI), which
resulted in enhanced accumulation of N-cadherin C-terminal fragment (CTF1, ~40 kDa). CTF2/N-cad (CTF2), a product
of the γ-secretase cleavage of N-cadherin, was released and translocated into the nuclear compartment in PMA-treated
cells. Moreover, CTF2 enhanced the effect of PMA-mediated MMP-9 gene expression as assessed by treatment with γI
or overexpression with exogenous CTF2. Additionally, siRNA silencing of N-cadherin decreased PMA-mediated MMP-9
expression and cell invasion. The outside-in signaling effect of MMP-9 in macrophage CM- or PMA-treated cell cultures
significantly enhanced NPC cell invasion via N-cadherin cleavage.
Conclusion: Extracellular and intracellular cleavage of N-cadherin might be involved in elevated MMP-9 expression
enhancing tumor cell invasion. Furthermore, N-cadherin–affected tumor progression might be via enhanced MMP-9
signaling in a cross-talk regulatory mechanism. N-cadherin might contribute to the invasive characteristics of carcinoma
cells by upregulating MMP-9, thereby leading to increased aggressive metastasis.
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Background
Human nasopharyngeal carcinoma (NPC) is a highly
invasive and metastatic head and neck cancer prevalent
in Southeast Asia [1, 2]. Although NPC is highly chemo-
sensitive, chemotherapy has been associated with recur-
rent or metastatic NPC [3]. One of the most striking
and consistent characteristics of NPC is the presence of
abundant leukocyte infiltrates consisting mainly of T
lymphocytes and macrophages, which suggests an
important link between pro-inflammatory factors and
carcinogenesis [1]. Tumor invasion is a multistep
process during which cell motility is coupled with prote-
olysis, and this process involves cell interaction with the
extracellular matrix (ECM) [4]. N-cadherin is critical for
the epithelial-to-mesenchymal transition (EMT) required
for highly invasive tumor growth [5]. However, the con-
tribution of N-cadherin to carcinoma cell invasion needs
investigation.
N-cadherin is a homophilic transmembrane cell adhesion
molecule. Increased N-cadherin expression is a hallmark of
EMT also associated with malignancy and metastasis [6].
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N-cadherin promotes tumor cell survival, migration and
invasion. Elevated N-cadherin level is often associated with
poor prognosis [4]. Despite accumulating evidence support-
ing the relationship of N-cadherin level and cancer progres-
sion, the effect of N-cadherin on tumor metastasis has not
been clearly demonstrated. Recent studies indicated that
the key role of N-cadherin in cell adhesion and motility is
its post-translational processing [5].
Metalloproteinase (MMP)-induced cadherin cleavage re-
sults in the shedding of the extracellular N-terminal amino
fragment (NTF) and the generation of a first C-terminal
fragment (CTF1, ~40 kDa) in the cytoplasmic compart-
ment. CTF1 is further processed by the presenilin-1–γ-
secretase complex in the juxta-membrane region, thereby
releasing the cytoplasmic domain (CTF2, ~35 kDa) [4]. A
regulatory function of CTFs has been implicated in cell
migration and invasion [4, 7]. CTFs were recently found
required for inducing MMP-9 in oral carcinoma cells [8].
MMP-9 is involved in the degradation of the ECM and
cleavage of cell adhesion molecules. MMP-9 has been
found to cause N-cadherin shedding that induced vascular
muscle cell proliferation [9]. The study suggested that
MMP-mediated proteolytic processing of N-cadherin
causes shedding of its extracellular and intracellular frag-
ments [10, 11]. The signaling properties of N-
cadherininclude cross-talk with cell surface partners such
as fibroblast growth factor receptors and with intracellular
cascades such as the β-catenin and p120-catenin pathways
[12]. Protein kinase C (PKC)–mediated ADAM10 expres-
sion has been implicated in N-cadherin cleavage leading to
glioblastoma cell migration [13]. N-cadherin may enhance
MMP-9 expression, thereby driving the malignant progres-
sion and invasion of tumor cells [6, 8]. MMP-9 and N-
cadherin are abundantly expressed in invasive carcinoma
cells [14, 15]. Thus, the dysregulation of MMP-9 and the
expression of N-cadherin may be essential for promoting
the aggressive invasion of carcinoma cells.
In this study, we investigated the effect of N-cadherin
on MMP-9-mediated cell invasion after treatment with
PMA (a potent tumor promoter) or macrophage condi-
tioned medium (CM) in NPC cells. Upregulation of
MMP-9 induced by PMA or macrophage CM stimula-
tion mediated cell invasion via N-cadherin cleavage.
Particularly, N-cadherin cleavage enhanced the expres-
sion of MMP-9. Thus, a cross-talk between N-cadherin
and MMP-9 might be implicated in enhanced carcinoma
cell invasion.
Methods
Cell culture and reagents
The human NPC cell lines NPC-TW076 and NPC-
TW039 were isolated from nasopharyngeal squamous
cell carcinoma [16] and maintained as previously
described [2, 17]. The anti-MMP-9 antibody used for
neutralizing MMP-9 activities in the conditioned medium
and for western blotting was purchased from Epitomics.
GM6001 (GM), a broad-spectrum MMP inhibitor, MMP9I,
a potent, selective and reversible MMP-9 inhibitor, and L-
685,458 (γI), an inhibitor of N-cadherin cleavage were from
BioVision. A mouse anti-N-cadherin antibody (610920,
clone 32, BD Biosciences) was used to recognize the intra-
cellular domain of N-cadherin. Other antibodies were from
Cell Signaling. Additional inhibitors, U0126 (MEK1/2 in-
hibitor), SB203680 (p38 mitogen-activated protein kinase
[MAPK] inhibitor), SP600125 (JNK inhibitor), and bisindo-
lylmaleimide (BIM, a protein kinase inhibitor), were from
BioVision or Enzo Life. 6-Amino-4-(4-phenoxyphenylethy-
lamino) quinazoline (QNZ), a NFκB activation inhibitor,
was from Cayman International.
Collection of conditioned media
NPC cells were seeded in 6-well plates at 3 × 105 cells
per well. Cells were cultured with and without PMA
(100 nM) for 10 h, washed with 1 X phosphate-buffered
saline (PBS) three times to completely remove PMA,
then incubated with fresh medium for 24 h. The result-
ing PMA-treated and -untreated conditioned media
(CM1 and C1, respectively) were collected and stored at
−20 °C. THP1-derived macrophages were generated as
described [18]. THP-1 monocytes were seeded in 6-well
plates at 4 × 106 cells per well in 3 ml completed
medium briefly. Cells were treated with 100 nM PMA
for 24 h, washed three times with 1X PBS, then incu-
bated for 48 h in 2 ml fresh completed medium. The
resulting macrophage CM (mϕCM) was collected, clari-
fied by centrifugation, then stored at −20°C. Conditioned
media from THP-1 monocytes (monoCM) was harvested
similarly.
siRNA transfection
Specific small interfering RNAs (siRNAs) were used to
silence MMP-9 and N-cadherin expression. An siRNA
targeting part of the N-cadherin mRNA was selected
and synthesized by Pharmacon Research Inc. The MMP-
9-specific siRNA was from Santa Cruz Biotechnology
and the negative control siRNA (Ngi), a scramble, was
as previously described [19]. NPC cells were transfected
with siRNA duplexes according to the manufacturer’s
protocol.
Preparations of cell lysates, subcellular fractions and
western blot analysis
Before exposure to PMA or mϕCM, cells were seeded in
6-well culture plates at 3 × 105 cells/well and treated
with siRNA or the inhibitors BIM (2 μM), γI (5 μM) or
MMP-9I (20 μM), U0126 (20 μM), SB203580 (20 μM),
SP600125 (20 μM) or QNZ (20 μM) [20, 21]. Cytosolic
and nuclear extracts were prepared by using the NE-
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PER nuclear and cytoplasmic extraction reagents kit
(Thermo Fisher Scientific). The cellular and subcellular ex-
tracts were prepared and separated on SDS-PAGE and
blotted onto polyvinylidene difluoride membranes (Immo-
bilon (TM)-P, Millipore) as described [17]. Blots were
probed with primary antibodies then appropriate horserad-
ish peroxidase-conjugated secondary antibodies. Immuno-
reactive protein bands were developed with the Enhanced
Chemiluminescence reagent (Perkin Elmer LAS Inc.).
Matrigel-coated invasion assay
The Boyden chamber invasion assay involved use of 6-
mm Transwell chambers containing polycarbonate
membranes with 8-μm pores (Becton-Dickinson). Cells
were re-suspended in medium containing 1 % fetal bo-
vine serum (FBS) and added to Matrigel-coated upper
chambers at 4 × 104 to 1 × 105 cells per well. The lower
chamber was filled with DMEM containing 5–10 % FBS
with and without 100 nM PMA or CM. After 24 h, cells
that migrated to the lower wells were fixed in 4 % para-
formaldehyde, stained with 0.25 % crystal violet, and
counted under a light microscope in five predetermined
fields (100X or 200X).
Gelatin zymography assay
CM was separated by 10 % SDS-PAGE with gels con-
taining 0.1 % gelatin. After electrophoresis, gels were
washed twice in washing buffer (2.5 % Triton X-100 in
dH2O) at room temperature for 30 min each time to re-
move SDS, then incubated in reaction buffer (10 mM
CaCl2 and 40 mM Tris–HCl, pH 8.0) at 37 °C for 12 h
to allow proteolysis of the gelatin substrate. The bands
corresponding to the expression of MMP-9 were visual-
ized by negative staining with Coomassie Brilliant blue
R-250 (Bio-Rad Laboratories), and molecular weights
were estimated by referencing pre-stainedSDS-PAGE
markers.
Construction of pMMP-9-Luc and pEGFP-CTF2 plasmids
and promoter reporter assay
An MMP-9 promoter fragment spanning nucleotides
−925 to +13 was synthesized from human genomic
DNA (Promega) by PCR as described [22]. The ampli-
fied PCR products were ligated into the pGL3-basic vec-
tor (Promega) to generate the plasmid pMMP9-Luc.
Transient transfection of the luciferase reporter plasmids
involved use of Lipofectamine 2000 (Invitrogen) accord-
ing to the manufacturer’s instructions. NPC cells were
seeded in 12-well plates and transfected with 0.5 μg
pMMP9-Luc and 0.5 μg pSV-β-galactosidase control
vector (Promega). At 24 h post-transfection, the levels of
firefly luciferase activity were measured in each sample
by using the Luciferase Assay System (Promega). The β-
galactosidase enzyme assay involved use of the same
lysates to standardize the transcription efficiency. The
relative amount of luciferase activity in the untreated
cells was set to 1.
Human N-cadherin in pCCL-c-MNDU3c-PGK (pCCL-
c-MNDU3c-PGK-EGFP) was a gift from Nora Heister-
kamp (Addgene plasmid #38153) [23]. The cytoplasmic
fragment (CTF2) of N-cadherin cDNA (Accession no.
NM_001792, 2663–3145 bp) was amplified by PCR with
the primer sequences 5′-CGAGCTCAAGCTTCGAAAC
GCCGGGATAAAGAACG-3′ and 5′-TACCGTCGACTG
CAGTCAGTCATCACCTCCACCAT-3′. The pEGFP-C
TF2 plasmid was assembled from the CTF2 cDNA and
the EcoRI-linearlized plasmid pEGFP-C1 (Clonetech, CA).
The DNA recombination involved use of the GeneArt
Seamless Cloning and Assembly Kit (Invitrogen).
Activation of pro-MMP-9 in vitro
Pro-MMP-9 (R&D Systems, 911-MPN-010) was acti-
vated by incubation for 24 h at 37 °C in TCNB buffer
(50 mM Tris, 10 mM CaCl2, 0.15 M NaCl, and 0.05 %
Brij). NPC cells were incubated with activated MMP-9
(0.1 nM) for 7 h, and the effects of MMP-9 on cellular
N-cadherin and cell invasion were determined.
Statistical analyses
Data are presented as mean ± SEM. The Kruskal–Wallis
test was used to compare differences in protein levels
among the three cell lines. Differences between any two
proteins were estimated by Dunn’s multiple comparisons
test. The Mann–Whitney U test was used to assess the
pre- and post-treatment protein levels in each cell line.
P < 0.05 was considered statistically significant.
Results
N-cadherin cleavage mediated the m ϕ CM-increased
expression of MMP-9
Tumor-associated macrophages are commonly found at
the invasive fronts of advanced carcinoma [24]. We
investigated the involvement of N-cadherin in
macrophage-induced NPC cell invasion. Cell invasion was
greater in mϕCM- than monoCM-treated NPC cells
(Fig. 1a). Furthermore, exposure to mϕCM increased
MMP-9expression and decreased the expression of
full-lengthN-cadherin (FL/N-cad, ~130 kDa) but did not
affect E-cadherin expression (Fig. 1b). L-685,458, a γ-
secretaseinhibitor (γI), can prevent the intracellular pro-
cessing of the C-terminal fragments of N-cadherin (CTFs/
N-cad) [25]. mϕCM affected the intracellular cleavage of
N-cadherin as seen by increased CTF1 expression and
decreased MMP-9 expression with γI treatment (Fig. 1c).
Thus, mϕCM enhanced the intracellular cleavage associ-
ated with mϕCM-increasedMMP-9 expression.
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MMP-9 induced N-cadherin cleavage and cell invasion after
PMA treatment
PKCs are involved in the initiation of N-cadherin cleav-
age and cell invasion in glioblastoma cells [13]. To
examine the involvement of N-cadherin in NPC cell in-
vasion, NPC cells were treated with PMA for various
times. PMA time-dependently upregulated MMP-9 and
downregulated FL/N-cad but did not affect the expres-
sion of E-cadherin (Fig. 2a). The observed PMA-
inducedMMP-9 upregulation was blocked by 1-hpre-
treatment with the broad-spectrum PKC inhibitor bisin-
dolylmaleimide (BIM) (Fig. 2b), so the process was PKC-
inducible.
CTF1/N-Cad (CTF1) is the product of extracellular
metalloproteases that cleave close to the interface be-
tween the extracellular and transmembrane regions of
N-cadherin [10]. CTF2/N-Cad (CTF2) results from sub-
sequent γ–secretase cleavage, which follows the removal
of the extracellular region by extracellular MMPs [26].
To analyze the possible PMA-mediatedN-cadherin intra-
cellular cleavage, the amount of CTF1 was validated in
NPC cells pre-treated with γI, then co-incubated with
and without PMA for 24 h. The intracellular CTFs were
recognized by the mouse anti-N-cadherin antibody (BD
Bioscience). The baseline accumulation of CTF1
(~40 kDa) was detected in cells with γI treatment
(Fig. 2c). Remarkably, PMA treatment after γI treatment
increased CTF1 expression approximately 2.3- and 3.1-
fold in NPC-TW039 and NPC-TW076 cells, respectively
(Fig. 2c). Therefore, PMA upregulated MMP-9 and the
extracellular and intracellular cleavage of N-cadherin.
N-cadherin cleavage enhanced MMP-9 expression
We investigated the role of N-cadherin cleavage in NPC
cell invasion. PMA-mediated cell invasion was markedly
abrogated by treatment with γI (Fig. 3a). Importantly, γI
treatment markedly reduced PMA-upregulatedMMP-9
and increased PMA-mediated accumulation of CTFs/N-
cad (Figs. 3b and 2c). Thus, cleavage of N-cadherin was
implicated in upregulated MMP-9 expression.
MMP-9 induced N-cadherin cleavage
We investigated the role of MMP-9 in N-cadherin cleavage
by treatment with an MMP inhibitor. PMA-
upregulatedMMP-9 expression was effectively abrogated
by treatment with a broad-spectrum MMP inhibitor
(GM6001, GM) that markedly diminished the cleavage of
N-cadherin (Fig. 4a), and the PMA-mediated cleavage of
N-cadherin and MMP-9 was markedly inhibited by a spe-
cific MMP-9 inhibitor (MP9I, Fig. 4b). To further validate
Fig. 1 Blockade of N-cadherin cleavage decreased m ϕ CM-induced cell invasion and MMP-9 levels. a m ϕ CM enhanced NPC cell invasion. NPC
cells were seeded into the inner well of the Boyden chamber, pre-coated with matrix-gel and monoCM or m ϕ CM, then introduced into the
outer well of the Boyden chamber for 24 h. Cells that invaded the lower surface of the filter were fixed, stained, photographed and counted. Represen-
tative plots of Matrigel invasion assay are shown. Data are mean±SEM. N = 3, *P<0.05. b NPC cells were treated with monoCM or m ϕ CM for 24 h, then
cell lysates underwent western blot analysis with indicated antibodies (N-cad, E-cad and MMP-9). c Blockade of N-cadherin cleavage by γI decreased m
ϕ CM-induced MMP-9 expression in NPC-TW039 cells. NPC cells were pre-treated with γI (5 μM), then exposed to m ϕ CM for 24 h. Cell lysates
underwent western blot analysis with indicated antibodies
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the function of MMP-9 in N-cadherin cleavage, NPC cells
were exposed to pure, activated or inactivated recombinant
MMP-9 protein. Treatment with pro-MMP-9 slightly de-
creased the expression of N-cadherin, but exposure to acti-
vated MMP-9 for 7 h significantly reduced the expression
of FL/N-cad (Fig. 4c). Hence, activated MMP-9 induced
the extracellular cleavage of N-cadherin. However, the
extracellular cleavage of N-cadherin on treatment with ac-
tivated recombinant MMP-9 alone did not induce NPC
cell invasion (data not shown).
PMA induced MMP-9 expression via activation of MAPK
or NF-κB signaling
During tumor progression, multiple signaling pathways
control the expression of PMA-mediatedMMP-9 [27].
We investigated the involvement of MAPKs (extracellu-
lar signal-regulated kinase 1/2 [ERK1/2], p38, and c-
JunN-terminal kinase [JNK]) and NF-κB signaling during
PMA-inducedMMP-9 expression and N-cadherin cleav-
age. Treatment with inhibitors of ERK1/2 and p38 or NF-
κB abrogated the PMA-upregulatedMMP-9 expression as
investigated by gelatin zymography (Fig. 5a). To examine
the effect of the MAPKs or NF-κB signaling on the re-
porter activity of MMP-9, NPC cells were transfected with
pGL-MMP9-Luc for 24 h and treated with an MAPK or
NF-κB inhibitor before exposure to PMA. Luciferase ac-
tivity induced by PMA was significantly suppressed on
treatment with an ERK1/2, p38 or NF-κB inhibitor
(Fig. 5b). Next, we examined the effect of MAPK or NF-
κB signaling on cleavage of N-cadherin.PMA-treated NPC
cells with an ERK1/2, p38 or NF-κB inhibitor incubation
showed no accumulation of CTF1/N-cad induced by γI
(Fig. 5c). Conversely, the inhibitors markedly abolished
the PMA-mediated cleavage of FL/N-cad. PMA-
mediatedMMP-9 expression may be via activation of
ERK1/2, p38 or NF-κB signaling. However, MAPK or NF-
κB signaling did not directly mediate the intracellular
cleavage of N-cadherin.
Cross-talk between N-cadherin and PMA-mediatedMMP-9
We examined the contribution of N-cadherin in NPC cells
and evaluated the cell–cell adhesion phenotype of NPC cell
Fig. 2 PMA induced the cleavage of N-cadherin.aN-cad and MMP9 expression with/without PMA treatment. NPC cells were exposed to PMA at the
indicated times, and cell lysates underwent immunoblotting. The relative band intensities of N-cadherin and MMP-9 proteins were normalized to
GAPDH by densitometry. Data are mean±SEM. *P<0.05, N = 3. b PMA induced MMP-9 expression via a PKC-dependent pathway. NPC cells were
pre-treated with BIM (2 μM) for 2 h, then PMA (100 nM) for 24 h. Cell lysates underwent western blot analysis with the indicated antibodies. c PMA
induced the cleavage of N-cadherin. NPC cells were pre-treated with L-685,458 (5 μM, γI), then exposed to PMA for 24 h. Cell lysates underwent
western blot analysis with the indicated antibodies. The ratio of FL/N-cad or CTF/N-cad to GAPDH was calculated. Data are mean±SEM. N = 3, *P<0.05
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lines that expressed N-cadherin by immunofluoresence
staining with N-cadherin antibodies. Control cells with
higher intensities of N-cadherin appeared similar to cobble-
stones (Fig. 6a), whereas N-cadherinsiRNA-transfected cells
seemed scattered and may be lost in cell–cell contact. To
examine the role of N-cadherin in cell invasion, NPC cells
were transfected with N-cadherin siRNA for 24 h, then ex-
posed to PMA. The invasive capacity was lower for of N-
cadherinsiRNA-transfected cells than negative control
siRNA (Ngi)-transfected cells (Fig. 6b). To independently
validate the interaction between N-cadherin and MMP-9,
NPC cells were transfected with MMP-9 or N-cadherin
siRNA for 24 h before PMA treatment. SiRNA knockdown
of MMP-9 efficiently reduced the expression of MMP-9
and significantly abolished the PMA-mediated cleavage of
N-cadherin (Fig. 6c). SiRNA silencing of N-cadherin signifi-
cantly reduced PMA-upregulatedMMP-9 expression.
MMP-9 in CM consistently exhibited a similar effect, as in-
vestigated by gelatin zymography (Fig. 6c). The data suggest
a cross-talk between N-cadherin and MMP-9 expression in
modulating PMA-mediated carcinoma cell invasion.
Upregulation of MMP-9 via N-cadherin cleavage
The possible outside-in signaling of MMP-9 via N-
cadherin cleavage warrants further exploration. NPC
cells were cultured with and without PMA for 8 h,
washed with 1X PBS three times then incubated with
normal culture medium for 24 h. The conditioned media
from the PMA-treated and untreated NPC cells was
collected (CM1 and C1, respectively). NPC cells were
exposed to CM1 or C1 for 24 h, and the effect of CM1
or C1 on invasion was analyzed by matrix-gel–coated
transwell assay. CM1 incubation significantly increased
NPC cell invasion (Fig. 7a) and reduced FL/N-cad pro-
tein level (Fig. 7b). The harvested CM of CM1- and C1-
treated cells was referred to as CM2 or C2, respectively,
and the level of MMP-9 in CM1 and CM2 was compared
on gelatin zymography. MMP-9 expression was markedly
greater in CM2 than CM1 (Fig. 7c). Remarkably, CM1-
mediatedMMP-9 expression in cell lysates and CM was
abrogated on γI treatment (Fig. 7d). The data also suggest
that intracellular cleavage after CM1 treatment plays an
important role in increased MMP-9 expression.
The NTF (~90 kDa) of N-cadherin plays a role in
modulating cell invasion [28]. PMA treatment might
induce the expression of various signaling molecules
(including the NTF) and their release into the CM. Cell
lysates or CM1 underwent western blot analysis with an
anti-NTF/N-cad antibody that recognizes the N-
terminal fragment of N-cadherin. A soluble fragment of
~90 kDa was detected in CM1 but not in cell lysates
(Fig. 8a ). We investigated the invasive capacity of NTF/
Fig. 3 Blockade of N-cadherin cleavage decreased PMA-mediated cell invasion and MMP-9 level. a γI treatment decreased PMA-induced cell invasion.
NPC cells were treated with γI in the inner well of the Boyden chamber, and PMA (100 nM) plus γI was introduced into the outer well for 24 h. Cells
that invaded the lower surface of the filter were fixed, stained and photographed. Representative images and statistical plots of the invasion assay are
shown. The relative cell invasion in the γI-plus-PMA–treated group was compared to PMA treatment alone. b γI treatment decreased the PMA-
mediatedMMP-9 expression. NPC cells were pre-treated with γI (5 μM), then exposed to PMA for 24 h. Cell lysates underwent immunoblotting with
the indicated antibodies. The relative MMP-9 expression was compared with the control group (PMA-untreated cells); N = 3, *P<0.05
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N-cad and MMP-9 in CM1. CM1 was pre-incubated
with the antibodies for IgG, MMP-9 or NTF/N-cad for
2 h before exposure to NPC cells for 24 h, then cell in-
vasion and MMP-9 levels in CM were observed. CM1
pre-incubated with anti-MMP-9 antibody did not trigger
NPC cell invasion (Fig. 8b) and was accompanied by re-
duced levels of MMP-9 (Fig. 8c). Therefore, MMP-9 in
the CM1 mediated NPC cell invasion.
PMA increased the CTF nuclear translocation and the
reporter activity of MMP-9
We assessed the possible signaling of CTFs of N-
cadherin in regulating MMP-9. NPC cells were pre-
treated with γI, then co-incubated with PMA for 8 h; the
distribution of CTFs in total cell lysates and cytosol/
nuclear fractions was detected. Consistent with results
in Fig. 3, treatment with γI increased CTF1 level in total
cell lysates distributed in the cytsol and nuclear fractions
(Fig. 9a, lane 2 in left and right panels, respectively). We
then investigated the subcellular distribution of CTF2.
Treatment with PMA increased CTF2 level in total cell
lysates distributed in the cytosol and nuclear fractions
(Fig. 9a, lane 3 in left and right panels, respectively).
Treatment with γI abrogated this PMA-mediated
CTF1 cleavage, which resulted in enhanced accumula-
tion of CTF1 and barely detectable amounts of CTF2
in total cell lysates and in cytosol or nuclear fractions
(Fig. 9a, lane 4 in left and right panels, respectively).
Thus, PMA-induced CTF1 cleavage may result in nu-
clear localization of CTF2.
Fig. 4 MMP-9 inhibitors abolished PMA-inducedN-cadherin cleavage. NPC cells were pre-treated with (a) GM6001 (GM, 10–20 μM) or (b) a specific
MMP-9 inhibitor (20 μM) for 2 h, then co-incubated with PMA (100 nM) for 24 h. Cell lysates underwent immunoblotting with the indicated antibodies.
The relative band intensities of FL/N-cad were compared with the control group (PMA-untreated cells), and relative expression (RLE) of N-cadherin is
shown as the ratio of GM-plus-PMA–treated group to PMA treatment alone. c The effect of pro-MMP-9 or activated MMP-9 on the cleavage of
N-cadherin.Pro-MMP-9 (R&D, 911-MPN-010) was activated by incubation in TCNB buffer for 24 h at 37 °C. NPC-TW039 cells were exposed to activated
MMP-9 or pro-MMP-9 (0.1 nM) for 7 h. Cell lysates underwent western blot analysis with anti-N-cadherin antibody. The relative expression of FL/N-cad
was compared to the control group (activated MMP-9-untreated cells); N = 3, *P<0.05
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Next, we transfected NPC cells with pGL-MMP9-
Luc for 24 h, then transfected cells were pretreated
with γI and co-incubated with PMA for 16 h. γI
significantly inhibited the luciferase activity induced
by PMA, which implies a signaling effect of intracel-
lular cleavage of N-cadherin on upregulated MMP-9
(Fig. 9b).
To determine whether CTF2 upregulated MMP-9,
we constructed a pEGFP-CTF2 plasmid with CTF2/
N-cad and EGFP. NPC cells were transfected with
pEGFP-CTF2 or pEGFP-C1 (empty vector with
EGFP) along with pGL-MMP9-Luc for 24 h and ex-
amined for PMA-inducedMMP-9 expression in NPC
cells expressing an exogenous CTF2 domain (with
EGFP) (~60 kDa) (Fig. 9c). Overexpression of CTF2
significantly enhanced the PMA-upregulatedMMP-9
protein level. To examine the effect of CTF2 on the
reporter activity of MMP-9, NPC cells were co-
transfected with pEGFP-CTF2 or pEGFP-C1 along
with pGL-MMP9-Luc for 24 h before exposure to
PMA for 6 h. Luciferase activity was significantly en-
hanced with CTF2 overexpression (Fig. 9d). Thus,
CTF2 could enhance the effect of PMA on MMP-9
gene regulation.
Discussion
N-cadherin, a hallmark of EMT, is associated with
carcinoma cell metastasis. This study demonstrated novel
roles for N-cadherin and MMP-9 in the NPC metastasis
process. Shedding of N-cadherin may contribute to the in-
vasion of carcinoma cells via upregulation of MMP-9.
Exposure to PMA or macrophage CM induced post-
translational cleavage of N-cadherin. Disruption of MMP-
9- or γ-secretase–mediated N-cadherin cleavage downreg-
ulated MMP-9 and linked these processes to carcinoma
invasion. Overexpression of CTF2/N-cad enhanced the
PMA regulation of MMP-9 expression. The outside-in sig-
naling effect of macrophage CM mediated by N-cadherin
cleavage depended on γ-secretase. We identified a cross-
talk between MMP-9 and N-cadherin cleavage involved in
the regulation of carcinoma cell invasion, which provides a
possible mechanism for MMP-9 in inflammatory-
mediated cell invasion via N-cadherin cleavage.
Inflammation is a driving force in carcinoma cell
metastasis [24]. A high density of infiltrated inflamma-
tory cells, particularly tumor-associated macrophages, is
commonly found at the invasive front of advanced car-
cinoma [24]. The infiltrated cells secrete a wide variety
of growth factors and cytokines to stimulate the growth,
Fig. 5 PMA or CM1 upregulated MMP-9 via the ERK, p38 MAPK and NF-κB pathways. a PMA (m ϕ CM) induced MMP-9 expression via activation of
MAPK and NF-κB pathways. NPC cells were pre-treated with specific inhibitors of ERK 1/2 (U0126, 10 μM), p38 (SB203580, 10 μM), JNK (SP600125,
10 μM) or NF-kB (QNZ, 10 μM) for 1 h, then treated with PMA (100 nM) or m ϕ CM for 18 h, and MMP-9 levels in the CM were determined by gelatin
zymography. The relative level of MMP-9 expression was compared in cells treated with MAPK or NF-κB inhibitor plus PMA and PMA treatment alone;
N = 3, *P<0.05. b PMA induced the reporter activity of MMP-9 in NPC cells. NPC 039 cells were transfected with pGL-MMP9-Luc for 24 h. Transfected
cells were treated with U0126, SB203580, or QNZ for 1 h, then exposed to PMA (100 nM) for 6 h. Luciferase activity is presented relative to the control
group. c MAPK or NF-kB signaling was not directly involved in the regulation of the intracellular cleavage of N-cadherin. NPC cells were pretreated with
the indicated inhibitors for 1 h before 8 h of PMA exposure. Cell lysates underwent immunoblotting with the indicated antibodies. The relative CTF1
accumulation was compared with the control group (PMA-untreated cells); N = 3, *P<0.05
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Fig. 6 Cross-talk regulation between N-cadherin cleavage and MMP-9 expression. a SiRNA silencing of N-cadherin disrupted the cell–cell adhesion. NPC
cells were transfected with N-cadherin siRNA for 24 h, then examined by immunofluoresence staining with anti-N-cadherin antibodies and analyzed by
confocal laser scanning microscopy. b Silencing of N-cadherin decreased PMA-mediated cell invasion. NPC cells were transfected with N-cadherin siRNA
for 24 h, then cell invasion was investigated by Boyden chamber assay. Representative images are shown and data are presented as mean±SEM.
c NPC cells were transfected with siRNA specific for MMP-9 or N-cadherin for 24 h, then exposed to PMA for 24 h. The transfected cells were cultured
with and without PMA for 24 h. The expression of MMP-9 and N-cadherin in cell lysates was assessed by western blot analysis with the indicated
antibodies. MMP-9 level in CM was detected by gelatin zymography. The relative expression of FL/N-cad or MMP-9 in MMP-9 siRNA- or N-cadsiRNA-
transfected cells was compared with Ng (non-specific control) siRNA (Ngi) -transfected cells after PMA treatment; N = 3, *P<0.05
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motility and invasiveness of tumor cells. MMPs mediate
the enhanced invasive ability of tumor cells co-cultured
with macrophages or macrophage CM [24]. Here, we in-
vestigated the outside-in signaling of MMP-9 in NPC
cells by exposing NPC cells to macrophage CM. Similar
to macrophage CM treatment, γI-induced blockage of
the intracellular cleavage of N-cadherin led to
accumulated CTFs and reduced expression of MMP-9
after PMA treatment (Figs. 2 and 3). This result high-
lights the role of MMP-9 in N-cadherin cleavage and the
signaling effect of N-cadherin cleavage in the upregula-
tion of MMP-9 in inflammatory cells.
Fig. 7 CM1 significantly enhanced cell invasion accompanied by increments of MMP-9 upregulation and N-cadherin cleavage. Briefly, NPC cells
were cultured with and without PMA for 8 h, then PMA-containing medium was completely removed and replaced with completed medium for
24 h. The CM was collected and referred to as CM1 or C1. a CM1 induced NPC cell invasion. The invasive capability of CM1-treated NPC cells was
investigated. CM1 was introduced into the outer well of NPC-cell–seeded Boyden chambers for 24 h. The invasive cells at the lower surface of
the membrane were fixed, stained, photographed and counted. Data are mean±SEM. *p<0.05, N = 3. b CM1 reduced the level of N-cad. NPC cells were
exposed to CM1 or C1 for 24 h, then cell lysates underwent western blot analysis. c CM1 upregulated MMP-9. NPC cells were treated with CM1 or C1
for 24 h, the CM was collected and referred to as CM2 or C2, respectively. The level of MMP-9 in CM1/CM2 was examined by gelatin zymography. Data
are mean±SEM. N = 3, *P<0.05. d Blockade of intracellular cleavage of N-cadherin decreased CM1-mediatedMMP-9 expression. NPC cells were
pre-treated with γI for 2 h and co-incubated with CM1 for 24 h, then cell lysates and CM underwent western blot analysis and gelatin zymography
Fig. 8 CM1-derived MMP-9 mediated cell invasion. C1 or CM1 was harvested as described in Fig. 7. a NTF/N-cad was detected in CM1. Equal
amounts of cell lysate or CM underwent western blot analysis with an anti-N-cadherin antibody (sc-7939) that recognizes the extracellular domain
(FL/N-cad, ~130 kDa; NTF/N-cad, ~90 kDa). b Co-incubation with an anti-MMP-9 antibody decreased CM1-mediated cell invasion. CM1 was
co-incubated with antibodies for IgG, MMP-9 or NTF/N-cad for 2 h, then introduced into the outer well of the Boyden chamber for 24 h. Cells on
the lower surface of the membrane were fixed and stained with crystal violet. Data are mean±SEM. N = 3, *P<0.05. c The expression of MMP-9 in
the CM from the outer well of the Boyden chamber was determined by gelatin zymography
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Carcinoma cells acquire their invasive phenotype by
overexpressing various MMPs that cleave ECM compo-
nents. MMPs regulate proliferation, adhesion, migration,
and metastasis by cleaving cell-surface proteins [4].
MMP-inducedN-cadherin cleavage results in shedding
of the extracellular NTF and generation of CTF1
(~40 kDa). CTF1 is further processed by a γ-secretase–
dependent cleavage that releases the cytoplasmic domain
(CTF2, ~35 kDa) [4]. PMA treatment decreased the ex-
pression of FL/N-cad (~130 kDa) (Fig. 2a, c). Treatment
with γI induced accumulation of CTF1 (~40 kDa), which
indicates a basal level of post-translational cleavage of N-
cadherin in NPC cells under normal growth conditions
(Fig. 2c). Notably, treatment with PMA or macrophage
CM enhanced the γI-mediated CTF1 accumulation (Figs. 1
and 2), which indicates induced γ-secretase-dependent
cleavage (or intracellular cleavage) of N-cadherin. Interest-
ingly, macrophage CM induced N-cadherin cleavage
without affecting E-cadherin cleavage in NPC cells
(Fig. 1b). A similar result was shown in PMA-treated NPC
cells (Fig. 2a), which suggests a unique role for N-
cadherin cleavage in NPC cell invasion.
PMA may induce various MMPs to cleave the ECM.
ADAM10, one of the many MMPs, has been extensively
shown to cleave N-cadherin [9, 13]. However, we found
that the expression of ADAM10 was not significantly
affected in NPC cells in response to PMA treatment
(Additional file 1: Figure S1). PMA time- and PKC-
dependently induced the expression of MMP-9 in N-
cadherin–presented NPC cell lines (Fig. 2). Whether the
expression of MMP-9 contributes to the cleavage of N-
cadherin remains for further study. Treatment with the
pan-MMP inhibitor or specific MMP-9 inhibitor rescued
the FL/N-cad level (Fig. 4a, b). Moreover, NTF/N-cad
(~90 kDa) was present in the CM after PMA treatment
(Fig. 8a), which indicates induced extracellular
Fig. 9 CTF2 enhanced the PMA-mediatedMMP-9 gene expression. a The nuclear translocation of CTFs/N-Cad was blocked by pretreatment with γI before
exposure to PMA. NPC cells were pretreated with γI for 2 h, then co-incubated with PMA for 16 h. Total cell lysates and sub-cellular fractions underwent
western blot analysis, and levels of CTFs/N-Cad were detected. GAPDH was a loading control for the cytosol fraction. Lamin B1 was a loading control for
the nuclear fraction. b The reporter activity of PMA-mediatedMMP-9 was inhibited after blockade of N-cadherin intracellular cleavage. NPC cells were
transfected with pGL-MMP9-Luc for 24 h, then pre-treated with γI for 2 h and co-incubated with PMA for 16 h. β-galactosidase activity in each transfection
was used to normalize luciferase activity. The luciferase activity is presented relative to the control group (PMA-untreated cells). Data are mean±SEM. N= 3,
*p<0.05. c Exogenous expression of CTF2/N-cad enhanced PMA-upregulatedMMP-9 expression. NPC cells were transfected with pEGFP-C1 (C1) or pEGFP-
CTF2 (CTF2), then treated with PMA for 16 h. Cell lysates underwent western blot analysis with the indicated antibodies. Exogenous CTF2-conjugated EGFP
is shown as a band of ~60 kDa. Data are mean±SEM. N= 3, *P<0.05. d Exogenous expression of CTF2 enhanced the reporter activity of MMP-9. NPC cells
were transfected with p-EGFP-CTF2 or pEGFP-C1 in the presence of pGL-MMP9-Luc for 24 h, then exposed to PMA for 6 h. Luciferase activity is relative to
the pEGFP-C1- transfected group. Data are mean±SEM. N= 3, *P<0.05
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cleavage. The extracellular cleavage was further con-
firmed by treatment with activated recombinant
MMP-9protein (Fig. 4c).
N-cadherin is one of the trans-membrane compo-
nents of the adherens junction, and its expression
and proteolytic cleavage might be closely associated
with cancer cell invasion [13]. SiRNA knockdown of
N-cadherin decreased PMA-mediatedMMP-9 expres-
sion (Fig. 6c). The recombinant activated MMP-9
alone could induce cleavage of N-cadherin (Fig. 4c) but
not NPC cell invasion. The impact on cell invasion may
depend on the intracellular cleavage of N-cadherin.
Furthermore, PMA-enhancedMMP-9 protein level was ef-
ficiently suppressed by γI treatment and enhanced by ec-
topic expression of CTF2 (Figs. 3 and 9c). A recent study
found that MMP-9 level in oral carcinoma cells was
reduced to the normal level with lack of the cytoplasmic
domain of N-cadherin, which suggests a vital role for
CTFs of N-cadherin in regulating MMP-9 [8]. Consist-
ently, our results indicated induced nuclear translocation
of CTFs by PMA, which was suppressed by γI treatment.
Moreover, the transactivation of MMP-9 was enhanced by
ectopic expression of CTF2 in PMA-treated NPC cells
(Fig. 9d). The results suggest a signaling role for CTFs/N-
cad in modulating MMP-9 gene expression. The CTFs of
N-cadherin form a complex with p120- and β-catenin and
with PS1 at the plasma membrane (25). MMP-9 and
MMP-12 cause N-cadherin shedding and induce vascular
smooth muscle cell proliferation via β-catenin signaling
[9]. We found that ectopic expression of CTF2 did not sig-
nificantly induce MMP-9 expression (Fig. 9). The effect of
CTF2 might be associated with the nuclear signaling of
subcellular distribution. However, the mechanistic sig-
naling of CTF2 needs to be investigated.
During tumor progression, a subset of primary tumor
cells may undergo molecular changes, thereby leading to
increased ability to survive, proliferate, invade, and even
metastasize. Multiple signaling pathways control the
expression of PMA-mediatedMMP-9 [27]. We found
ERK1/2, p38, and NF-κB signaling pathways involved in
PMA-inducedMMP-9 expression and promoter activity
(Fig. 5). Treatment with MAPK inhibitors or NF-
κBinhibitor suppressed the expression of PMA-
mediatedMMP-9, which then suppressed the extracellu-
lar cleavage of N-cadherin and sequential intracellular
cleavage of N-cadherin (Fig. 5). N-cadherin may have
contributed to the invasive characteristics of carcinoma
cells by upregulating MMP-9 in response to MAPK or
NF-κB signaling, thereby increasing the aggressive me-
tastasis. The effect of N-cadherin cleavage on NPC cell
invasion might be a secondary inflammation response.
In addition, we found that MMP-9 in CM1 induced cell
invasion and N-cadherin cleavage, which increased MMP-
9 expression (Fig. 7c). However, the outside-in signaling
effect of MMP-9 also depended on γ-secretase cleavage
(Fig. 7d). This finding provided a possible link between
MMP-9 and N-cadherin in inflammatory-mediated cell
invasion. Given the restricted pattern of N-cadherin ex-
pression in carcinoma cells, the cleavage of N-cadherin
enhancing cell invasion via increased MMP-9 levels indi-
cated a cross-talk between MMP-9 and N-cadherin in car-
cinoma cells (Fig. 10). The impact of N-cadherin cleavage
on MMP-9 expression might depend on the cellular con-
text and be associated with level of intracellular cleavage.
Fig. 10 A model proposed for the cross-talk between N-cadherin cleavage and MMP-9 expression in NPC cell invasion
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Conclusions
Elevated level of MMPs in the tumor microenvironment
could activate stromal-like cells to drive cancer progres-
sion via further MMP production [29]. In this study, N-
cadherin affected tumor progression by potentiating
MMP-9 signaling in a cross-talk regulatory mechanism
(Fig. 10). The expression of N-cadherin in metastatic
cancer cells suggests that it may be a therapeutic target
for advanced cancers. Our findings may reveal an
important factor in diagnosing malignant diseases and
designing effective anti-metastatic therapies.
Additional file
Additional file 1: Figure S1. The expression of the precursor and
active form of ADAM10 after PMA treatment. NPC cells were treated with
PMA (100 nM) for the indicated times. Cell lysates underwent western
blot analysis to detect levels of the precursor and active form of
ADAM10. In response to PMA treatment, the expression of ADAM10 was
not significantly changed in NPC cells. (TIF 645 kb)
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